Krystal Biotech, Inc.
KRYS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $79,365 | $38,334 | $35,733 | $45,479 |
| Dep. & Amort. | $1,609 | $1,543 | $1,634 | $1,555 |
| Deferred Tax | -$24,680 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $14,119 | $13,478 | $13,356 |
| Change in WC | -$27,877 | $494 | -$18,535 | -$5,661 |
| Other Non-Cash | $11,242 | -$1,761 | -$1,341 | -$1,886 |
| Operating Cash Flow | $39,659 | $52,729 | $30,969 | $52,843 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,704 | -$1,904 | -$6,204 | -$801 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$98,373 | -$113,899 | -$137,806 | -$143,472 |
| Inv. Sales/Matur. | $95,791 | $105,278 | $88,806 | $60,495 |
| Other Inv. Act. | $0 | $0 | $435 | $0 |
| Investing Cash Flow | -$4,286 | -$10,525 | -$54,769 | -$83,778 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $3,714 | $1,796 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$5 | $0 | -$12,466 | $2,428 |
| Financing Cash Flow | $3,709 | $1,796 | -$12,466 | $2,428 |
| Forex Effect | -$307 | $1,059 | $171 | -$594 |
| Net Chg. in Cash | $38,775 | $45,059 | -$36,095 | -$29,101 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $353,829 | $308,770 | $344,865 | $373,966 |
| End Cash | $392,604 | $353,829 | $308,770 | $344,865 |
| Free Cash Flow | $37,955 | $50,825 | $24,765 | $52,042 |